High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) ...
China is moving fast to dominate biotechnology, and the U.S. risks falling behind permanently unless it takes action over the next three years, a congressional commission said. Congress should invest ...
Countering the development and potential use of weapons of mass destruction has grown more complex with biotechnology advances that could be exploited by bad actors as well as rampant disinformation ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results